Loyal Valley Capital (LVC) is a thematic, research-driven private equity firm established in 2015 that invests in middle-market companies positioned to benefit from secular industry transformations in China, focusing on New Consumer, Healthcare, and Advanced Manufacturing sectors.
48% of their portfolio is in Biotech & Life Sciences. Deal activity increased 400% year-over-year (5 deals in the last 12 months). Average disclosed round size is $130.0M (across 36 rounds with reported amounts).
Portfolio
36
Fund Size
$465M
Top Stage
Series B
Last 12 Mo
5
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
50 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Bristar Immunotech | Series C | — | Jul 2026 |
 Yoltech Therapeutics | Series C | $70M | May 2026 |
| YYolTech | Series C | $70M | May 2026 |
| VVivacta Biotechnology | Series A | $50M | Apr 2026 |
 Vivacta | Series A | $50M | Apr 2026 |
| Bristar Immunotech | Series C | — | Jan 2026 |
 Leads Biolabs | Ipo | — | Jul 2025 |
| MMediLink | Series B | $70M | Apr 2022 |
| MMediLink Therapeutics | Series B | $70M | Apr 2022 |
| MMediLink Therapeutics | Series B | $70M | Mar 2022 |
 DP Technology | Series B | $100M | Jan 2022 |
 Sciwind | Series C | $70M | Oct 2021 |
 Alebund | Series B | $54.5M | Sep 2021 |
| AAbogen | Series C | $700M | Aug 2021 |
| AAbogen Biosciences | Series C | $700M | Aug 2021 |
 Edigene | Series B | — | Apr 2021 |
| MMediLink | Series A | — | Mar 2021 |
| MMediLink Therapeutics | Series A | $50M | Mar 2021 |
 Regor Therapeutics | Series B | $90M | Feb 2021 |
| RRegor | Series B | $90M | Feb 2021 |
| Leads Biolabs | Series C | — | Jan 2021 |
 JW Therapeutics | Ipo | $300M | Nov 2020 |
| JW Therapeutics | Series B | $100M | Jun 2020 |
 RemeGen | Growth | $100M | Apr 2020 |
 Genecast | Series E | — | Jan 2020 |
Page 1 of 2
Top Co-Investors
LAV10 shared
OrbiMed7 shared
Legend Capital7 shared
LYFE Capital5 shared
HighLight Capital5 shared
Apricot Capital5 shared
Lake Bleu Capital4 shared
Vivo Capital4 shared
GL Ventures4 shared
Hudson Bay Capital Management3 shared
IDG Capital3 shared
BioTrack Capital3 shared
MPC3 shared
Trustbridge Partners3 shared
Yunfeng Capital2 shared
5Y Capital2 shared
Boyu Capital2 shared
Gaorong Capital2 shared
Last updated: 20 October 2026